Research Papers:
Dishevelled-1 DIX and PDZ domain lysine residues regulate oncogenic Wnt signaling
PDF | Full Text | Supplementary Files | How to cite | Press Release
Metrics: PDF 1322 views | Full Text 3419 views | ?
Abstract
Monica Sharma1, Isabel Castro-Piedras1, Fahmida Rasha1, Sabarish Ramachandran2, Souad R. Sennoune2, Kathryn Furr1, Sharilyn Almodovar1, Vadivel Ganapathy2, Matthew B. Grisham1, Rakhshanda Layeequr Rahman3 and Kevin Pruitt1
1 Immunology and Molecular Microbiology, Texas Tech University Health Sciences Center, Lubbock, TX, USA
2 Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX, USA
3 Department of Surgery, Texas Tech University Health Sciences Center, Lubbock, TX, USA
Correspondence to:
Kevin Pruitt, | email: | [email protected] |
Keywords: dishevelled (DVL); post-translational modification; lysine residue; gene expression; chromatin immunoprecipitation (ChIP)
Received: August 03, 2021 Accepted: September 24, 2021 Published: October 26, 2021
ABSTRACT
DVL proteins are central mediators of the Wnt pathway and relay complex input signals into different branches of the Wnt signaling network. However, molecular mechanism(s) that regulate DVL-mediated relay of Wnt signals still remains unclear. Here, for the first time, we elucidate the functional significance of three DVL-1 lysines (K/Lys) which are subject to post-translational acetylation. We demonstrate that K34 Lys residue in the DIX domain regulates subcellular localization of β-catenin, thereby influencing downstream Wnt target gene expression. Additionally, we show that K69 (DIX domain) and K285 (PDZ domain) regulate binding of DVL-1 to Wnt target gene promoters and modulate expression of Wnt target genes including CMYC, OCT4, NANOG, and CCND1, in cell line models and xenograft tumors. Finally, we report that conserved DVL-1 lysines modulate various oncogenic functions such as cell migration, proliferation, cell-cycle progression, 3D-spheroid formation and in-vivo tumor growth in breast cancer models. Collectively, these findings highlight the importance of DVL-1 domain-specific lysines which were recently shown to be acetylated and characterize their influence on Wnt signaling. These site-specific modifications may be subject to regulation by therapeutics already in clinical use (lysine deacetylase inhibitors such as Panobinostat and Vorinostat) or may possibly have prognostic utility in translational efforts that seek to modulate dysfunctional Wnt signaling.

PII: 28089